Bharat Rasayan Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Valuation

Technical Trends Show Signs of Stabilisation

The primary catalyst for the upgrade stems from a shift in the technical grade from bearish to mildly bearish, indicating a tentative improvement in market sentiment. Weekly technical indicators such as the MACD and KST have turned mildly bullish, suggesting short-term momentum is gaining traction. The Dow Theory on a weekly basis also supports this mild bullishness, although monthly indicators remain bearish, reflecting lingering caution among longer-term investors.

Other technical measures present a mixed picture: the Relative Strength Index (RSI) shows no clear signal on both weekly and monthly charts, while Bollinger Bands remain mildly bearish. Daily moving averages continue to trend mildly bearish, and On-Balance Volume (OBV) lacks a definitive trend weekly but is mildly bearish monthly. This blend of signals points to a market that is cautiously optimistic but not yet decisively bullish.

Price action supports this technical shift, with the stock closing at ₹1,373.00 on 11 August 2026, up 0.96% from the previous close of ₹1,360.00. The intraday range between ₹1,347.20 and ₹1,437.20 shows some volatility but also buying interest near the lower end of the range. Despite this, the stock remains significantly below its 52-week high of ₹3,030.25, underscoring the challenges it faces in regaining investor confidence.

Valuation Metrics Turn More Attractive

Alongside technical improvements, Bharat Rasayan’s valuation grade has been upgraded from attractive to very attractive. The company currently trades at a price-to-earnings (PE) ratio of 14.31, which is significantly lower than many of its peers in the pesticides and agrochemicals industry. For comparison, Bayer CropScience trades at a PE of 25.53, BASF India at 27.91, and Anupam Rasayan at a steep 80.99.

Other valuation multiples reinforce this positive view. The enterprise value to EBITDA (EV/EBITDA) ratio stands at 10.10, well below the industry heavyweights such as Bayer CropScience (19.27) and BASF India (17.72). The price-to-book value ratio is 1.79, indicating the stock is trading at a reasonable premium to its net asset value. The PEG ratio of 1.08 suggests that the stock’s price is fairly aligned with its earnings growth potential, which is modest but positive.

Return on capital employed (ROCE) and return on equity (ROE) further support the valuation upgrade. The latest ROCE is 17.22%, while ROE stands at 12.52%, both reflecting efficient capital utilisation and profitability relative to peers. Dividend yield remains minimal at 0.03%, consistent with the company’s focus on reinvestment and growth.

Financial Trend: Mixed Signals Amidst Growth and Challenges

Despite the positive valuation and technical signals, Bharat Rasayan’s financial trend remains mixed. The company reported strong quarterly results for Q4 FY25-26, with profit before tax (PBT) excluding other income rising 45.57% to ₹41.43 crores and profit after tax (PAT) surging 68.1% to ₹42.25 crores. Debtors turnover ratio for the half-year period is at a healthy 3.22 times, indicating efficient receivables management.

However, long-term growth metrics paint a less favourable picture. Operating profit has declined at an annualised rate of 4.17% over the past five years, and the stock’s total returns have underperformed the broader market benchmarks. Over the last year, Bharat Rasayan’s stock price has fallen by 47.49%, compared to a modest 1.65% decline in the Sensex. Year-to-date returns are down 38.32%, while the Sensex has fallen 7.84% in the same period.

Over three and five years, the stock’s returns remain deeply negative at -39.86% and -57.47% respectively, while the Sensex has delivered positive returns of 19.57% and 43.97%. This underperformance highlights the challenges the company faces in translating operational improvements into sustained shareholder value.

Quality Assessment: Stable but Limited Growth Prospects

Bharat Rasayan’s quality grade remains steady but unremarkable, reflected in its Hold rating. The company maintains a very low average debt-to-equity ratio of 0.04 times, signalling a conservative capital structure and limited financial risk. Promoters continue to hold a majority stake, providing stability in ownership and strategic direction.

Nonetheless, the company’s long-term growth prospects are constrained by subdued operating profit growth and persistent stock underperformance. While recent quarterly earnings growth is encouraging, the broader financial trend suggests that investors should remain cautious and monitor future quarters for confirmation of a sustained turnaround.

Investment Outlook and Conclusion

The upgrade of Bharat Rasayan Ltd’s investment rating from Sell to Hold reflects a cautious optimism driven by improved technical indicators and a more attractive valuation profile. The company’s current trading multiples suggest it is undervalued relative to its industry peers, supported by solid returns on capital and recent earnings growth.

However, investors should weigh these positives against the company’s long-term financial challenges, including negative operating profit growth and significant stock underperformance versus the broader market. The technical signals, while improved, remain mixed and suggest that the stock is in a tentative recovery phase rather than a confirmed uptrend.

Given these factors, Bharat Rasayan is positioned as a hold for investors who favour a value-oriented approach with an eye on improving momentum but who remain wary of the risks posed by the company’s historical growth trajectory. Monitoring upcoming quarterly results and broader sector developments will be crucial to reassessing the stock’s potential for a further upgrade.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →